RSS feed

Publications by Inge-Margrethe Gilboe

32 publications found

Original articles

Garen T, Lerang K, Hoffmann-Vold AM, Andersson H, Midtvedt Ø, Brunborg C, Kilian K, Gudbrandsson B, Gunnarsson R, Norby G, Chaudhary A, Thoen J, Forseth KØ, Fresjar K, Førre Ø, Haugen M, Haga HJ, Gran JT, Gilboe IM, Molberg Ø, Palm Ø (2019)
Mortality and causes of death across the systemic connective tissue diseases and the primary systemic vasculitides
Rheumatology (Oxford), 58 (2), 313-320
DOI 10.1093/rheumatology/key285, PubMed 30281089

Götestam Skorpen C, Lydersen S, Gilboe IM, Skomsvoll JF, Salvesen KÅ, Palm Ø, Koksvik HSS, Jakobsen B, Wallenius M (2018)
Women with systemic lupus erythematosus get pregnant more easily than women with rheumatoid arthritis
Rheumatology (Oxford), 57 (6), 1072-1079
DOI 10.1093/rheumatology/key049, PubMed 29554346

Skorpen CG, Lydersen S, Gilboe IM, Skomsvoll JF, Salvesen KÅ, Palm Ø, Svean Koksvik HS, Jakobsen B, Wallenius M (2017)
Influence of disease activity and medications on offspring birth weight, pre-eclampsia and preterm birth in systemic lupus erythematosus: a population-based study
Ann Rheum Dis, 77 (2), 264-269
DOI 10.1136/annrheumdis-2017-211641, PubMed 29092851

Götestam Skorpen C, Lydersen S, Gilboe IM, Skomsvoll JF, Salvesen KÅ, Palm Ø, Koksvik HSS, Jakobsen B, Wallenius M (2017)
Disease Activity During Pregnancy and the First Year Postpartum in Women With Systemic Lupus Erythematosus
Arthritis Care Res (Hoboken), 69 (8), 1201-1208
DOI 10.1002/acr.23102, PubMed 27696790

Garabet L, Gilboe IM, Mowinckel MC, Jacobsen AF, Mollnes TE, Sandset PM, Jacobsen EM (2016)
Antiphospholipid Antibodies are Associated with Low Levels of Complement C3 and C4 in Patients with Systemic Lupus Erythematosus
Scand J Immunol, 84 (2), 95-9
DOI 10.1111/sji.12445, PubMed 27135178

Tamirou F, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Fiehn C, Ayala Guttierez Mdel M, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, Houssiau FA, MAINTAIN Nephritis Trial Group (2015)
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis
Ann Rheum Dis, 75 (3), 526-31
DOI 10.1136/annrheumdis-2014-206897, PubMed 25757867

Lerang K, Gilboe IM, Steinar Thelle D, Gran JT (2014)
Mortality and years of potential life loss in systemic lupus erythematosus: a population-based cohort study
Lupus, 23 (14), 1546-52
DOI 10.1177/0961203314551083, PubMed 25209070

Gunnarsson R, Andreassen AK, Molberg Ø, Lexberg ÅS, Time K, Dhainaut AS, Bertelsen LT, Palm Ø, Irgens K, Becker-Merok A, Nordeide JL, Johnsen V, Pedersen S, Prøven A, Garabet LS, Garen T, Aaløkken TM, Gilboe IM, Gran JT (2013)
Prevalence of pulmonary hypertension in an unselected, mixed connective tissue disease cohort: results of a nationwide, Norwegian cross-sectional multicentre study and review of current literature
Rheumatology (Oxford), 52 (7), 1208-13
DOI 10.1093/rheumatology/kes430, PubMed 23407386

Lerang K, Gilboe I, Garen T, Thelle DS, Gran JT (2012)
High incidence and prevalence of systemic lupus erythematosus in Norway
Lupus, 21 (12), 1362-9
DOI 10.1177/0961203312458168, PubMed 22914817

Ørstavik K, Svalheim S, Gunnarsson R, Gilboe IM, Torbergsen T (2012)
[A seriously ill patient who does not wake up after mechanical ventilation]
Tidsskr Nor Laegeforen, 132 (7), 822-5
DOI 10.4045/tidsskr.11.0357, PubMed 22511094

Lerang K, Gilboe IM, Gran JT (2011)
Differences between rheumatologists and other internists regarding diagnosis and treatment of systemic lupus erythematosus
Rheumatology (Oxford), 51 (4), 663-9
DOI 10.1093/rheumatology/ker318, PubMed 22157467

Stoenoiu MS, Aydin S, Tektonidou M, Ravelingien I, le Guern V, Fiehn C, Remy P, Delahousse M, Petera P, Quémeneur T, Vasconcelos C, D'Cruz D, Gilboe IM, Jadoul M, Karras A, Depresseux G, Guillevin L, Cervera R, Cosyns JP, Houssiau FA, MAINTAIN Nephritis Trial Group (2011)
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial
Nephrol Dial Transplant, 27 (5), 1924-30
DOI 10.1093/ndt/gfr553, PubMed 22110048

Gunnarsson R, Molberg O, Gilboe IM, Gran JT, PAHNOR1 Study Group (2011)
The prevalence and incidence of mixed connective tissue disease: a national multicentre survey of Norwegian patients
Ann Rheum Dis, 70 (6), 1047-51
DOI 10.1136/ard.2010.143792, PubMed 21398332

Houssiau FA, D'Cruz D, Sangle S, Remy P, Vasconcelos C, Petrovic R, Fiehn C, de Ramon Garrido E, Gilboe IM, Tektonidou M, Blockmans D, Ravelingien I, le Guern V, Depresseux G, Guillevin L, Cervera R, MAINTAIN Nephritis Trial Group (2010)
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: results from the MAINTAIN Nephritis Trial
Ann Rheum Dis, 69 (12), 2083-9
DOI 10.1136/ard.2010.131995, PubMed 20833738

Norby GE, Strøm EH, Midtvedt K, Hartmann A, Gilboe IM, Leivestad T, Stenstrøm J, Holdaas H (2010)
Recurrent lupus nephritis after kidney transplantation: a surveillance biopsy study
Ann Rheum Dis, 69 (8), 1484-7
DOI 10.1136/ard.2009.122796, PubMed 20498208

Halvorsen EH, Pollmann S, Gilboe IM, van der Heijde D, Landewé R, Ødegård S, Kvien TK, Molberg Ø (2007)
Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity
Ann Rheum Dis, 67 (3), 414-7
DOI 10.1136/ard.2007.080267, PubMed 18006540

Smerdel-Ramoya A, Finholt C, Lilleby V, Gilboe IM, Harbo HF, Maslinski S, Førre Ø, Thorsby E, Lie BA (2005)
Systemic lupus erythematosus and the extended major histocompatibility complex--evidence for several predisposing loci
Rheumatology (Oxford), 44 (11), 1368-73
DOI 10.1093/rheumatology/kei015, PubMed 16174649

Viken MK, Amundsen SS, Kvien TK, Boberg KM, Gilboe IM, Lilleby V, Sollid LM, Førre OT, Thorsby E, Smerdel A, Lie BA (2005)
Association analysis of the 1858C>T polymorphism in the PTPN22 gene in juvenile idiopathic arthritis and other autoimmune diseases
Genes Immun, 6 (3), 271-3
DOI 10.1038/sj.gene.6364178, PubMed 15759012

Gilboe IM, Kvien TK, Uhlig T, Husby G (2001)
Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables
Ann Rheum Dis, 60 (12), 1103-9
DOI 10.1136/ard.60.12.1103, PubMed 11709451

Gilboe IM, Kvien TK, Husby G (2001)
Disease course in systemic lupus erythematosus: changes in health status, disease activity, and organ damage after 2 years
J Rheumatol, 28 (2), 266-74
PubMed 11246660

Gilboe IM, Kvien TK, Haugeberg G, Husby G (2000)
Bone mineral density in systemic lupus erythematosus: comparison with rheumatoid arthritis and healthy controls
Ann Rheum Dis, 59 (2), 110-5
DOI 10.1136/ard.59.2.110, PubMed 10666165

Gilboe IM, Kvien TK, Husby G (1999)
Health status in systemic lupus erythematosus compared to rheumatoid arthritis and healthy controls
J Rheumatol, 26 (8), 1694-700
PubMed 10451064

Jensen JL, Bergem HO, Gilboe IM, Husby G, Axéll T (1999)
Oral and ocular sicca symptoms and findings are prevalent in systemic lupus erythematosus
J Oral Pathol Med, 28 (7), 317-22
DOI 10.1111/j.1600-0714.1999.tb02047.x, PubMed 10432198

Anderson IF, Helve T, Hannonen P, Leirisalo-Repo M, Gilboe IM, Nissilä M, Keystone EC, Kraag GR, Bjørneboe O, Chalmers A, Dovland H, Mueller E, Richard F, Whatmough I, Schmidt AG, Kovarik JM (1999)
Conversion of patients with rheumatoid arthritis from the conventional to a microemulsion formulation of cyclosporine: a double blind comparison to screen for differences in safety, efficacy, and pharmacokinetics
J Rheumatol, 26 (3), 556-62
PubMed 10090162

Gilboe IM, Husby G (1999)
Application of the 1982 revised criteria for the classification of systemic lupus erythematosus on a cohort of 346 Norwegian patients with connective tissue disease
Scand J Rheumatol, 28 (2), 81-7
DOI 10.1080/030097499442531, PubMed 10229136

Haugen MA, Høyeraal HM, Larsen S, Gilboe IM, Trygg K (1992)
Nutrient intake and nutritional status in children with juvenile chronic arthritis
Scand J Rheumatol, 21 (4), 165-70
DOI 10.3109/03009749209099216, PubMed 1529282

Review articles

Norby GE, Lerang K, Holdaas H, Gran JT, Strøm EH, Draganov B, Os I, Hartmann A, Gilboe IM (2010)
[Lupus-nephritis--diagnosis and treatment]
Tidsskr Nor Laegeforen, 130 (11), 1140-4
DOI 10.4045/tidsskr.09.0583, PubMed 20531500

Bertsias GK, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Boumpas DT, Gordon C (2008)
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus: literature based evidence for the selection of endpoints
Ann Rheum Dis, 68 (4), 477-83
DOI 10.1136/ard.2007.083030, PubMed 18434449

Gordon C, Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostál C, Font J, Gilboe IM, Houssiau F, Huizinga TW, Isenberg D, Kallenberg CG, Khamashta MA, Piette JC, Schneider M, Smolen JS, Sturfelt G, Tincani A, Van Vollenhoven R, Boumpas DT (2008)
EULAR points to consider for conducting clinical trials in systemic lupus erythematosus
Ann Rheum Dis, 68 (4), 470-6
DOI 10.1136/ard.2007.083022, PubMed 18388158

Bertsias G, Ioannidis JP, Boletis J, Bombardieri S, Cervera R, Dostal C, Font J, Gilboe IM, Houssiau F, Huizinga T, Isenberg D, Kallenberg CG, Khamashta M, Piette JC, Schneider M, Smolen J, Sturfelt G, Tincani A, van Vollenhoven R, Gordon C, Boumpas DT, Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (2007)
EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics
Ann Rheum Dis, 67 (2), 195-205
DOI 10.1136/ard.2007.070367, PubMed 17504841

Skomsvoll JF, Aasarød K, Salvesen KA, Hoff M, Wallenius M, Rødevand E, Koksvik HS, Gilboe IM, Nossent HC (2007)
[Systemic lupus erythematosus and pregnancy]
Tidsskr Nor Laegeforen, 127 (6), 725-9
PubMed 17363983

Theses

Gilboe IM (2002)
Disease manifestations and disease course in systemic lupus erythematosus: comparison to rheumatoid arthritis and healthy controls
In Series of dissertations submitted to the Faculty of Medicine, University of Oslo, Unipub, Oslo, no. 5, 1 b. (flere pag.)
BIBSYS 020491026, ISBN 82-8080-001-8